|1Domina, EA |
1R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology of the NAS of Ukraine, Kyiv
|Dopov. Nac. akad. nauk Ukr. 2019, 7:81-88|
A determination and a prediction of the individual radiation sensitivity (IRS) of a person remains an actual problem in the field of radiobiology. The chromosomal aberrations of a stable type, which are recognized as radiation in dicators, may be involved in the malignant cell transformation. Under the classical cytogenetic analysis (a uniform staining of cells), stable aberrations appear only in 20 % of cases. The use of differential cell coloration makes it possible to identify the most complete spectrum of radiation-induced chromosome aberrations, including stable types, which act as the threat of an increased carcinogenic risk. The aim is to determine the frequency and spectrum of radiation-induced chromosome aberrations in blood lymphocytes of persons with a high IRS. A cytogenetic examination of persons with a high individual radiosensitivity (coefficientirs 1.2—1.7) was carried out on the basis of the differentiated coloring of chromosomal preparations in blood lymphocytes. A high individual radiosensitivity to a radiation is combined with the stable-type aberrations of chromosomes 3, 5, 9, and 14. This indicates an increased risk of developing a cancer. It has also been shown that the chromosomes participate in the rearrangements with different frequencies, which indicates their interindividual sensitivity to radiation. Within the framework of the performed cytogenetic study, the highest sensitivity to the irradiation was found in chromosome 5. Chromosome Y was not involved in the formation of the rearrangements. The introduction of the developed “Passport of individual radiosensitivity of a person according to the cytogenetic parameters” is recommended in order to improve the quality of the clinical examination of professionals working in the field of ionizing radiation.
|Keywords: blood lymphocytes, carcinogenic risk, chromosomal rearrangements, differentiated color, individual radiosensitivity|
1. Domina, E. A. & Chekhun, V. F. (2013). Experimental validation of prevention of the development of stochastic effects of low doses of ionizing radiation based on the analysis of human lymphocytes’ chromosome aberrations. Exp. Oncol., 35, No. 1, pp. 65-68.
2. Domina, E. A. (2016). Chromosomal abnormalities in blood lymphocytes of primary cancer patients in the post-Chernobyl period. Science Rise: Biol. Sci., No. 1, pp. 20-25 (in Russian).
3. Domina, E. A. (2018). Evaluation of the effect of professional irradiation on cytogenetic parameters of peripheral blood lymphocytes. Dopov. Nac. acad. nauk Ukr., No. 10, pp. 112-119 (in Russian). https://doi.org/10.15407/dopovidi2018.10.112
4. Domina, E. A., Ryabchenko, N. M., Drugyna, M. O. & Chekhun, V. F. (2007). Cytogenetic method (G2- assay) of determining the individual radiosensitivity of a person for the purpose of primary prevention of radiogenic cancer. Methodical recommendations. Kyiv: Ministry of Health care of Ukraine (in Ukrainian).
5. Cytogenetic dosimetry: Applications in preparedness for and response to radiation emergencies (2011). Vienna: IAEA.
6. Zerova-Lyubimova, T. E. & Gorovenko, N. G. (2003). Standards for the analysis of human chromosome preparations. Methodical recommendations. Kyiv: Ministry of Health care of Ukraine (in Ukrainian).
7. Arefi, M., Garcia, J. L., Penarrubia, M. J. et al. (2012). Incidence and clinical characteristics of myeloproliferative neoplasms displaying a PDGFRB rearrangement. Eur. J. Haematol., 89, No. 1, pp. 37-41. https://doi.org/10.1111/j.1600-0609.2012.01799.x
8. Giagounidis, A., Mufti, G. J, Fenaux, P. et al. (2014). Lenalidomide as a disease-modifying agent in patients with del(5q) myelodysplastic syndromes: linking mechanism of action to clinical outcomes. Ann. Hematol., 93, No. 1, pp. 1-11. https://doi.org/10.1007/s00277-013-1863-5
9. Kumar, M. S., Narla, A., Nonami, A. et al. (2011). Coordinate loss of a microRNA and protein-coding gene cooperate in the pathogenesis of 5q- syndrome. Blood, 118, No. 17, pp. 4666-4673. https://doi.org/ 10.1182/blood-2010-12-324715
10. Schmutz, J., Martin, J., Terry, A. et al. (2004). The DNA sequence and comparative analysis of human chromosome 5. Nature, 431, pp. 268-274.
11. Brunelli, M., Fiorentino, M., Gobbo, S. et al. (2011). Many facets of chromosome 3p cytogenetic findings in clear cell renal carcinoma: the need for agreement in assessment FISH analysis to avoid diagnostic errors: a review. Histol Histopathol., 26, No. 9, pp. 1207-1213.
12. De Braekeleer, E., Douet-Guilbert, N., Rowe, D. et al. (2011). ABL1 fusion genes in hematological malignancies: a review. Eur. J. Haematol., 86, No. 5, pp. 361-371. https://doi.org/10.1111/j.1600-0609.2011.01586.x
13. Gabrea, A., Bergsagel, P. L. & Kuehl, W. M. (2006). Distinguishing primary and secondary translocations in multiple myeloma: a review. DNA Repair (Amst.), 5, No. 9-10, pp. 1225-1233.
14. Vitolo, U., Ferreri, A. J. & Montoto, S. (2008). Follicular lymphomas. Crit. Rev. Oncol. Hematol., 66, No. 3, pp. 248-261. https://doi.org/10.1016/j.critrevonc.2008.01.014
15. Domina, E. A. & Drugyna, M. O. (2018). Passport of individual radiosensitivity of a person according to the cytogenetic indices. Newsletter No. 322-2018. Kyiv: Ministry of Health care of Ukraine (in Ukrainian).